Q32 Bio annual operating margin
2018
2019
2020
2021
2022
2023
2025
Q32 Bio Operating Margin Growth & History (QTTB)
Q32 Bio's operating margin was 31.45% for fiscal 2025.
View full Q32 Bio company overviewQ32 Bio annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 31.45% | +4205.76 pp |
| 2023 | 2023-12-31 | −4,174.31% | −19.66 pp |
| 2022 | 2022-12-31 | −4,154.64% | −3872.20 pp |
| 2021 | 2021-12-31 | −282.44% | +4538.54 pp |
| 2020 | 2020-12-31 | −4,820.98% | +1778.24 pp |
| 2019 | 2019-12-31 | −6,599.22% | −5473.21 pp |
| 2018 | 2018-12-31 | −1,126.01% | — |
Q32 Bio quarterly operating margin
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2023 | 2023-06-30 | −2,055.08% | +1474.47 pp |
| Q1 2023 | 2023-03-31 | −919.33% | +3771.20 pp |
| Q4 2022 | 2022-12-31 | −4,301.00% | −108.35 pp |
| Q3 2022 | 2022-09-30 | −4,097.51% | −2269.18 pp |
| Q2 2022 | 2022-06-30 | −3,529.55% | −2132.57 pp |
| Q1 2022 | 2022-03-31 | −4,690.52% | −4686.73 pp |
| Q4 2021 | 2021-12-31 | −4,192.64% | −1151.73 pp |
| Q3 2021 | 2021-09-30 | −1,828.32% | +3158.10 pp |
| Q2 2021 | 2021-06-30 | −1,396.98% | +4898.79 pp |
| Q1 2021 | 2021-03-31 | −3.79% | +6202.33 pp |
| Q4 2020 | 2020-12-31 | −3,040.92% | +1498.87 pp |
| Q3 2020 | 2020-09-30 | −4,986.42% | +2108.36 pp |
| Q2 2020 | 2020-06-30 | −6,295.77% | +840.20 pp |
| Q1 2020 | 2020-03-31 | −6,206.12% | +3098.69 pp |
| Q4 2019 | 2019-12-31 | −4,539.79% | −2853.08 pp |
| Q3 2019 | 2019-09-30 | −7,094.78% | −6118.82 pp |
| Q2 2019 | 2019-06-30 | −7,135.97% | −6173.82 pp |
| Q1 2019 | 2019-03-31 | −9,304.81% | −8357.43 pp |
| Q4 2018 | 2018-12-31 | −1,686.71% | — |
| Q3 2018 | 2018-09-30 | −975.97% | — |
| Q2 2018 | 2018-06-30 | −962.15% | — |
| Q1 2018 | 2018-03-31 | −947.39% | — |
Q32 Bio operating margin trends
Over the last five reported fiscal years, Q32 Bio's operating margin increased from −6,599.22% to 31.45%, a change of +6630.67 percentage points. The latest reported quarter, Q2 2023, shows −2,055.08%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Q32 Bio filings at SEC.gov ↗